Lugol's iodine identifies synchronous invasive carcinoma—time for a clinical trial

References 

1. Weijers M, Snow GB, Bezemer PD, van der Wal JE, van der Waal I. The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. J Oral Pathol Med. 2002;31(1):11–15
   • MEDLINE
   • CrossRef
2. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(4):444–446
   • Abstract
   • Full-Text PDF (1722 KB)
   • CrossRef
3. Inoue H, Rey JF, Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer. Endoscopy. 2001;33(1):75–79
4. He S, Guo GM, Liu FX, Huang XP, Xu X, Cai Y, et al. Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2008;134(March (3)):307–315
   • CrossRef
5. McMahon J, Devine JC, McCaul JA, McLellan DR, Farrow A. Use of Lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg. 2010;48:84–87
   • Abstract
   • Full Text
   • Full-Text PDF (284 KB)
   • CrossRef
6. Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, et al. In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2009;
7. Sreedharan A, Rembacken BJ, Rotimi O. Acute toxic gastric mucosal damage induced by Lugol's iodine spray during chromoendoscopy. Gut. 2005;54(6):886–887
   • MEDLINE
   • CrossRef